A Study Evaluating Tolerability, Pharmacokinetics, and Preliminary Efficacy of HC-1119 in Patients.
Clinical trial NCT03774056 · COMPLETED
Trial details
- NCT number
- NCT03774056
- Sponsor
- Hinova Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-10
- Primary completion
- 2018-09-26
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.